Company page

Nuformix Plc

Nuformix Plc (Ticker: NFX) is a public company based in the UK with a market capitalization of approximately £5.79 million. The company focuses on developing innovative therapies through its proprietary drug reformulation technology. Nuformix aims to enhance the efficacy and safety of existing drugs, positioning itself in the pharmaceutical sector.